English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/34441
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Immune regulation based on the targeting of early activation molecules

AuthorsSánchez-Madrid, Francisco; Martínez-Alonso, Carlos; Sancho, David; Engel, Pablo; Esplugues, Enric; Vega Ramos, Javier; Lauzurica, Pilar
Issue Date6-Jan-2005
CitationUS 2005002929 (A1)
AbstractDisclosed are methods of treating subjects having disorders or conditions characterized by an unwanted immune response including administering an effective amount of an early activation molecule agonist, antagonist or depletor, to the subject. Human monoclonal antibodies specific to the early activation molecules, and methods of use, are also disclosed.
DescriptionFecha de presentación internacional: 02.02.2004. - Titular: Consejo Superior de Investigaciones Científicas (CSIC)
Appears in Collections:(CBM) Patentes
Files in This Item:
File Description SizeFormat 
US2005002929A1.pdf6,4 MBAdobe PDFThumbnail
Show full item record

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.